Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma
Abstract
Treatment failures in cancers, including multiple myeloma (MM), are most likely due to the persistence of a minor population of tumor-initiating cells (TICs), which are noncycling or slowly cycling and very drug resistant.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Aug 12, 2019
- Source ID
- 10.1093/jnci/djz159
Entities
People
- Fenghuang Zhan
- Gail A Bishop
- Gregory S. Thomas
- Guido Tricot
- Hua Bai
- Huojun Cao
- Ivana Frech
- Jiliang Xia
- Jumei Shi
- Kalyan Nadiminti
- Lijuan Chen
- Michael Tomasson
- Minjie Gao
- Mohamed E. Salama
- Peter Altevogt
- Reinaldo Franqui-machin
- Siegfried Janz
- Ye Yang
- Yogesh Jethava
- Yujie Wu
- Yuqi Zhu
Organizations
- Leukemia & Lymphoma Society
- Medical College of Wisconsin
- Multiple Myeloma Research Foundation
- Nanjing Medical University
- National Natural Science Foundation of China
- Tongji University
- University of Iowa
- University of Utah